Ethinyl Estradiol
From DrugPedia: A Wikipedia for Drug discovery
(Difference between revisions)
m |
m (1 revision) |
||
Line 1: | Line 1: | ||
+ | '''Ethinyl Estradiol''' | ||
+ | '''Pubchem(5991)''' | ||
+ | A semisynthetic alkylated ESTRADIOL with a 17-alpha-ethinyl substitution. It has high estrogenic potency when administered orally, and is often used as the estrogenic component in ORAL CONTRACEPTIVES. | ||
+ | |||
+ | '''KEGG PATHWAY'''(C07534,D00554) | ||
- | + | '''Category''' Hormone | |
- | + | ||
- | + | '''Activity''' Estrogen | |
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | {| border="1;width:100%; height:200px;style=text-align:center" | |
+ | |+'''Table I:''' | ||
+ | |- | ||
+ | ! style="background:brown; color:white" |Physical Property | ||
+ | ! style="background:brown; color:white" |Value | ||
+ | ! style="background:brown; color:white" |Units | ||
+ | ! style="background:brown; color:white" |Temp (deg C) | ||
+ | ! style="background:brown; color:white" |Source | ||
+ | |- | ||
+ | |Melting Point | ||
+ | |183 | ||
+ | |deg C | ||
+ | |EXP | ||
+ | |- | ||
+ | |log P (octanol-water) | ||
+ | |3.67 | ||
+ | |(none) | ||
+ | |EXP | ||
+ | |- | ||
+ | |Water Solubility | ||
+ | |11.3 | ||
+ | |mg/L | ||
+ | |27 | ||
+ | |EXP | ||
+ | |- | ||
+ | |Vapor Pressure | ||
+ | |2.67E-09 | ||
+ | |mm Hg | ||
+ | |25 | ||
+ | |EST | ||
+ | |- | ||
+ | |Henry's Law Constant | ||
+ | |7.94E-12 | ||
+ | |atm-m3/mole | ||
+ | |25 | ||
+ | |EST | ||
+ | |- | ||
+ | |Atmospheric OH Rate Constant | ||
+ | |1.25E-10 | ||
+ | |cm3/molecule-sec | ||
+ | |25 | ||
+ | |EST | ||
+ | |- | ||
+ | |} | ||
+ | {| border="1;width:100%; height:200px;style=text-align:center" | ||
+ | |+'''Table I:''' | ||
+ | |- | ||
+ | ! style="background:brown; color:white" |Organism | ||
+ | ! style="background:brown; color:white" |Test Type | ||
+ | ! style="background:brown; color:white" |Route | ||
+ | ! style="background:brown; color:white" |Reported Dose (Normalized Dose) | ||
+ | ! style="background:brown; color:white" |Effect | ||
+ | ! style="background:brown; color:white" |Source | ||
+ | |- | ||
+ | |mouse | ||
+ | |LD50 | ||
+ | |intraperitoneal | ||
+ | |250mg/kg (250mg/kg) | ||
+ | |BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD | ||
- | + | BEHAVIORAL: ATAXIA | |
+ | KIDNEY, URETER, AND BLADDER: OTHER CHANGES | ||
+ | |Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 18, Pg. 2583, 1990. | ||
+ | |- | ||
+ | |mouse | ||
+ | |LD50 | ||
+ | |oral | ||
+ | |950mg/kg (950mg/kg) | ||
+ | | | ||
+ | |Drugs in Japan Vol. -, Pg. 222, 1995. | ||
+ | |- | ||
+ | |mouse | ||
+ | |LD50 | ||
+ | |subcutaneous | ||
+ | |> 3gm/kg (3000mg/kg) | ||
+ | |BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) | ||
+ | |BLOOD: HEMORRHAGE Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 18, Pg. 2583, 1990. | ||
+ | |- | ||
+ | |rat | ||
+ | |LD50 | ||
+ | |intraperitoneal | ||
+ | |471mg/kg (471mg/kg) | ||
+ | |BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD | ||
- | + | BEHAVIORAL: ATAXIA | |
+ | KIDNEY, URETER, AND BLADDER: OTHER CHANGES | ||
+ | |Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 18, Pg. 2583, 1990. | ||
+ | |- | ||
+ | |rat | ||
+ | |LD50 | ||
+ | |oral | ||
+ | |960mg/kg (960mg/kg) | ||
+ | | | ||
+ | |Drugs in Japan Vol. -, Pg. 222, 1995. | ||
+ | |- | ||
+ | |rat | ||
+ | |LD50 | ||
+ | |subcutaneous | ||
+ | |> 2gm/kg (2000mg/kg) | ||
+ | |BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) | ||
- | + | BLOOD: HEMORRHAGE | |
+ | |Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 18, Pg. 2583, 1990. | ||
+ | |- | ||
+ | |women | ||
+ | |TDLo | ||
+ | |oral | ||
+ | |21mg/kg/21D-I (21mg/kg) | ||
+ | |LUNGS, THORAX, OR RESPIRATION: DYSPNEA | ||
- | + | GASTROINTESTINAL: NAUSEA OR VOMITING | |
- | + | |Lancet. Vol. 1, Pg. 1479, 1973. | |
- | + | |- | |
- | + | |} | |
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + |
Revision as of 07:12, 13 February 2009
Ethinyl Estradiol Pubchem(5991)
A semisynthetic alkylated ESTRADIOL with a 17-alpha-ethinyl substitution. It has high estrogenic potency when administered orally, and is often used as the estrogenic component in ORAL CONTRACEPTIVES.
KEGG PATHWAY(C07534,D00554)
Category Hormone
Activity Estrogen
Physical Property | Value | Units | Temp (deg C) | Source |
---|---|---|---|---|
Melting Point | 183 | deg C | EXP | |
log P (octanol-water) | 3.67 | (none) | EXP | |
Water Solubility | 11.3 | mg/L | 27 | EXP |
Vapor Pressure | 2.67E-09 | mm Hg | 25 | EST |
Henry's Law Constant | 7.94E-12 | atm-m3/mole | 25 | EST |
Atmospheric OH Rate Constant | 1.25E-10 | cm3/molecule-sec | 25 | EST |
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
mouse | LD50 | intraperitoneal | 250mg/kg (250mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
BEHAVIORAL: ATAXIA KIDNEY, URETER, AND BLADDER: OTHER CHANGES | Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 18, Pg. 2583, 1990. |
mouse | LD50 | oral | 950mg/kg (950mg/kg) | Drugs in Japan Vol. -, Pg. 222, 1995. | |
mouse | LD50 | subcutaneous | > 3gm/kg (3000mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) | BLOOD: HEMORRHAGE Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 18, Pg. 2583, 1990. |
rat | LD50 | intraperitoneal | 471mg/kg (471mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
BEHAVIORAL: ATAXIA KIDNEY, URETER, AND BLADDER: OTHER CHANGES | Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 18, Pg. 2583, 1990. |
rat | LD50 | oral | 960mg/kg (960mg/kg) | Drugs in Japan Vol. -, Pg. 222, 1995. | |
rat | LD50 | subcutaneous | > 2gm/kg (2000mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)
BLOOD: HEMORRHAGE | Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 18, Pg. 2583, 1990. |
women | TDLo | oral | 21mg/kg/21D-I (21mg/kg) | LUNGS, THORAX, OR RESPIRATION: DYSPNEA
GASTROINTESTINAL: NAUSEA OR VOMITING | Lancet. Vol. 1, Pg. 1479, 1973. |